<http://schema.org/potentialAction>
_:b1
<http://www.genengnews.com/gen-news-highlights/phase-iii-study-shows-exelixis-cabozantinib-nearly-triples-pfs-in-metastatic-medullary-thyroid-/81246851/?kwrd=Exelixis>